LABT:NASDAQ
Lakewood-amedex Biotherapeutics Inc
$1.99
arrow_upward
+6.99%(+0.13) 1D
$1.90
arrow_downward
-4.52% (-0.090)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LABT...
Open
$1.92
High
$2.15
Low
$1.89
Mkt. cap
4.72M
Avg. vol.
887.22K
Volume
290.22K
52-wk high
$98.20
52-wk low
$1.66
EPS
-$0.27
No. of employees
5
Open
$1.92
High
$2.15
Low
$1.89
Mkt. cap
4.72M
Avg. vol.
887.22K
Volume
290.22K
52-wk high
$98.20
52-wk low
$1.66
EPS
-$0.27
No. of employees
5
News stories
From web sources and news partners
Investing.com
·
1 day ago
Lakewood-Amedex receives approval to start phase 2a trial
PR Newswire
·
2 days ago
Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot Ulcers
Stock Titan
·
2 days ago
A new gel for infected diabetic foot ulcers is ready for a clinical trial
About Lakewood-amedex Biotherapeutics Inc